|
|
| S |
M |
T |
W |
T |
F |
S |
| |
|
|
|
1
|
2
|
3
|
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
|
Today is Sep 5, 2010
|
|
|
| December 1, 2005 |
| Time: |
12:00 PM to 1:00 AM |
| Topic: |
Adverse Events in Clinical Trials |
| Speaker: |
Theresa Haedrich |
| Location: |
Jazz Pharmaceuticals |
|
3180 Porter Drive |
|
Palo Alto, California |
|
Get Map and Directions |
|
|
**************************** PLEASE NOTE !!!! ************************
THIS MEETING IS RESCHEDULED FOR THURDAY, DEC. 1, 2005, 12:00 TO 1:00 PM AT JAZZ PHARMACEUTICALS
WE APOLOGIZE FOR THE INCONVENIENCE IN YOUR SCHEDULES. PLEASE SUBMIT A NEW RSVP BY WEDNESDAY, NOV. 30TH IF YOU ARE ABLE TO ATTEND THE MEETING ON DEC. 1ST.
JAZZ PHARMACEUTICALS WILL PROVIDE LUNCH AT NO COST.
THANK YOU FOR YOUR UNDERSTANDING.
******************************************************************************
The presentation will cover:
- Various SAE Issues in Clinical Trials
- Challenges in Reconciliation, Standards and Protocol Development
- Issues relating to Investigator-sponsored trials
- Clinical Trial Directive
NOTE:
Jazz Pharmaceuticals will provide lunch to the attendees. The number of attendees is required in advance. Please submit your rsvp no later than Wednesday, November 23rd. Thank you. |
|
| Speaker Biography |
|
| Theresa has worked in Drug Safety for over 20 years. She has successfully established Drug Safety Departments for local companies with newly approved drugs, incorporating clinical and post-marketing safety. The bulk of her experience has been from Syntex Corporation in Palo Alto. She also worked as a consultant for Roche and COR Therapeutics. Her safety experience includes vaccines, biologics and pharmaceuticals. Theresa is currently the Director of Drug Safety at Jazz Pharmaceuticals. |